Associations Between Preconception Weight Loss Drug Use, Gestational Weight Gain, and Development of Gestational Diabetes
Background: Weight loss drugs (WLD) including glucagon-like peptide-1 agonists (GLP-1 agonists) are increasingly used for obesity to promote weight loss and insulin sensitivity. Currently, recommendations are to halt all WLD in pregnancy given undetermined safety profiles or previously identified te...
I tiakina i:
| Ngā kaituhi matua: | , , , , , |
|---|---|
| Hōputu: | Artigo |
| Reo: | Inglês |
| I whakaputaina: |
SAGE Publishing
2025-01-01
|
| Rangatū: | Women's Health Reports |
| Ngā marau: | |
| Urunga tuihono: | https://www.liebertpub.com/doi/10.1177/26884844251401523 |
| Ngā Tūtohu: |
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!
|